Indxx Global Generics & New Pharma Index

The VANECK VECTORS ETF TRUST GENERIC DRUGS ETF (NASDAQ: GNRX) debuted in January in what can be considered a bit of inauspicious timing for a new healthcare exchange-traded fund to come to market. Interesting Debut Timing Amid election year posturing, slumping biotechnology stocks and the U.S....

Mergers and acquisitions have been one of the key drivers behind the healthcare sector's leadership during the current bull market. That catalyst has been dealt a blow at the hands of the U.S. government's efforts to crack down on inversion deals, but that does not mean healthcare M&A...

In recent years, exchange-traded funds tracking the healthcare sector, the third-largest sector weight in the S&P 500, have become increasingly refined. For example, since late 2014, ETFs have come to market that offer investors exposure to biotech stocks at specific stages of FDA clinical...